跳至主要内容
临床试验/NCT01637350
NCT01637350Unknown不适用

The Effect of Blood Glucose to Different Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes

Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1

研究概览

简要总结

Different digestive tract reconstruction will affect the blood glucose level of gastric cancer with type 2 diabetes. Subtotal gastrectomy with Billroth II reconstruction and total gastrectomy with Roux-en-Y reconstruction may help to improve glycaemic control which includes fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C -peptide and body weight of gastric cancer patients with type 2 diabetes.

详细描述

Different digestive tract reconstruction will affect the blood glucose level of gastric cancer with type 2 diabetes. Subtotal gastrectomy with Billroth II reconstruction and total gastrectomy with Roux-en-Y reconstruction may help to improve glycaemic control which includes fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C -peptide and body weight of gastric cancer patients with type 2 diabetes.

The investigators will observed fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C -peptide and body weight of the patients preoperation, 14 days postoperation 3 month and 6month postoperation. The investigators will observed the effect of blood glucose to different digestive tract reconstruction after gastrectomy of gastric cancer with type 2 diabetes

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-75 years old,gastric cancer ,can be performed operation
  • with type 2 diabetes,fasting blood glucose > 6.1mmol/L
  • without serious underlying diseases which may affect the metabolism and nutrient uptake
  • without serious underlying diseases which may affect anesthesia and operation
  • can be performed subtotal or total gastrectomy, predicted survival period > 6months
  • no other abdominal operation
  • preoperation consultation
  • informed consent

排除标准

  • recurrent,metastasis or die
  • patient requests for quit

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验